Tel-Instrument Electronics Corp. Reports Net Sales of $3.17 Million for Third Quarter 2022
Tel-Instrument Electronics Corp. (OTCQB: TIKK) reported a net income of $195K ($0.04 per share) on revenues of $3.17 million for Q3 FY2022, marking a 19% revenue increase year-over-year. Operating expenses dropped 10% to $1.1 million. The company achieved an operating income of $293K, up from a loss of $224K in the prior year. Cash balances increased to $7.3 million. However, ongoing supply chain challenges are anticipated to impact Q4 revenues. The company remains in a strong financial position to manage disruptions while progressing on product development.
- Revenues increased 19% to $3.17 million compared to the previous year.
- Operating income improved to $293K from a loss of $224K year-over-year.
- Cash balances rose to $7.3 million, an increase from $5.5 million at FY start.
- Successful Critical Design Review for the Lockheed Martin F-35 project, expected to generate new revenues.
- Positive customer reception for the SDR/OMNI test set, with production deliveries expected in Q2 2022.
- Ongoing supply chain interruptions expected to negatively affect Q4 revenues.
- Vendor lead times have doubled or tripled, complicating manufacturing efforts.
Highlights include:
-
Revenues for the third quarter increased to
, a$3.17 million 19% increase from the year-ago quarter. -
Quarterly operating expenses decreased
10% to due to tight cost controls and a funded engineering project.$1.1 million -
Operating income increased to
for the current quarter as compared to a loss of$293 K in the year-ago quarter.$224 K -
Nine-month operating income increased to
versus$1.4 million in the year-ago period.$327 K -
Nine-month net income increased to
, or$1.77 million per common share.$0.47 -
Cash balances improved to
, compared to$7.3 million at the start of the fiscal year.$5.5 million -
Net worth improved to
compared to$6.8 million at the start of the fiscal year.$5.2 million
Mr. Jeffrey O’Hara, Tel-Instrument’s President and CEO commented, “The Company recorded a profitable third quarter despite ongoing supply chain interruptions. Vendor lead times doubling and tripling in some cases with no sign of improvement in sight. This is causing ongoing issues in manufacturing and will negatively impact fourth quarter revenues. We are ordering additional components from our vendors to take the extended lead times into account. The positive news is that we are in a strong financial position to weather this supply disruption. We are also excited by the positive initial reception we have seen from customers on the SDR/OMNI test set. We are still working through component shortages on this test set, but initial production deliveries are still expected to commence in the second quarter of calendar year 2022. We believe that this will be a strong competitor in both commercial and military avionic and communication test set markets. The Lockheed Martin F-35 MADL development program had a successful Critical Design Review (“CDR”) in December. This contract will generate non-recurring engineering revenues over the next several quarters and should result in ongoing production revenues in what is essentially a new market for TIC. We are also actively working with the
With respect to the Aeroflex litigation, the Kansas Appeals Court is still working remotely and is not able to access the documents due to security restrictions. Aeroflex recently filed a motion with the Appeals Court to substantially increase the Bond Amount from the
About
Tel-Instrument is a leading designer and manufacturer of avionics test and measurement solutions for the global commercial air transport, general aviation, and government/military aerospace and defense markets. Tel-Instrument provides instruments to test, measure, calibrate, and repair a wide range of airborne navigation and communication equipment. For further information please visit our website at www.telinstrument.com.
This press release includes statements that are not historical in nature and may be characterized as “forward-looking statements,” including those related to future financial and operating results, benefits, and synergies of the combined companies, statements concerning the Company’s outlook, pricing trends, and forces within the industry, the completion dates of capital projects, expected sales growth, cost reduction strategies, and their results, long-term goals of the Company and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. All predictions as to future results contain a measure of uncertainty and, accordingly, actual results could differ materially. Among the factors which could cause a difference are: changes in the general economy; changes in demand for the Company’s products or in the cost and availability of its raw materials; the actions of its competitors; the success of our customers; technological change; changes in employee relations; government regulations; litigation, including its inherent uncertainty; difficulties in plant operations and materials; transportation, environmental matters; and other unforeseen circumstances. A number of these factors are discussed in the Company’s previous filings with the
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
|
2021 |
|
|
2021 |
|
|||
|
|
(unaudited) |
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash |
|
$ |
5,288,810 |
|
|
$ |
3,485,275 |
|
Accounts receivable, net |
|
|
1,385,384 |
|
|
|
1,933,321 |
|
Inventories, net |
|
|
2,748,275 |
|
|
|
3,437,989 |
|
Restricted cash to support appeal bond |
|
|
2,011,050 |
|
|
|
2,011,050 |
|
Prepaid expenses and other current assets |
|
|
286,507 |
|
|
|
263,067 |
|
Total current assets |
|
|
11,720,026 |
|
|
|
11,130,702 |
|
|
|
|
|
|
|
|
|
|
Equipment and leasehold improvements, net |
|
|
127,322 |
|
|
|
200,769 |
|
Operating lease right-of-use assets |
|
|
1,768,343 |
|
|
|
1,922,805 |
|
Deferred tax asset, net |
|
|
2,396,594 |
|
|
|
2,675,040 |
|
Other long-term assets |
|
|
35,108 |
|
|
|
35,110 |
|
Total assets |
|
$ |
16,047,393 |
|
|
$ |
15,964,426 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES & STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Operating lease liabilities – current portion |
|
$ |
192,487 |
|
|
$ |
201,883 |
|
Accounts payable |
|
|
438,569 |
|
|
|
906,149 |
|
Deferred revenues - current portion |
|
|
123,615 |
|
|
|
150,709 |
|
Accrued expenses ‐vacation pay, payroll and payroll withholdings |
|
|
376,073 |
|
|
|
457,232 |
|
Accrued legal damages |
|
|
6,045,924 |
|
|
|
5,889,023 |
|
Accrued expenses - other |
|
|
220,115 |
|
|
|
365,975 |
|
Total current liabilities |
|
|
7,396,783 |
|
|
|
7,970,971 |
|
|
|
|
|
|
|
|
|
|
Operating lease liabilities – long-term |
|
|
1,575,856 |
|
|
|
1,720,921 |
|
Long term debt - PPP |
|
|
- |
|
|
|
722,577 |
|
Deferred revenues – long-term |
|
|
307,578 |
|
|
|
332,428 |
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
9,280,217 |
|
|
|
10,746,897 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
|
|
|
Preferred stock, 1,000,000 shares authorized, par value |
|
|
|
|
|
|
|
|
Preferred stock, 500,000 shares
issued and outstanding, par value |
|
|
3,695,998 |
|
|
|
3,695,998 |
|
Preferred stock, 166,667 shares
issued and outstanding, par value |
|
|
1,147,367 |
|
|
|
1,147,367 |
|
Common stock, 7,000,000 shares authorized, par value 3,255,887 shares issued and outstanding, respectively |
|
|
325,586 |
|
|
|
325,586 |
|
Additional paid-in capital |
|
|
7,098,468 |
|
|
|
7,318,620 |
|
Accumulated deficit |
|
|
(5,500,243 |
) |
|
|
(7,270,042 |
) |
Total stockholders’ equity |
|
|
6,767,176 |
|
|
|
5,217,529 |
|
Total liabilities and stockholders’ equity |
|
$ |
16,047,393 |
|
|
$ |
15,964,426 |
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) |
||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
3,171,532 |
|
|
$ |
2,672,742 |
|
|
$ |
10,914,787 |
|
|
$ |
8,948,575 |
|
Cost of sales |
|
|
1,763,739 |
|
|
|
1,661,653 |
|
|
|
5,824,341 |
|
|
|
5,066,052 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin |
|
|
1,407,793 |
|
|
|
1,011,089 |
|
|
|
5,090,446 |
|
|
|
3,882,523 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
|
523,966 |
|
|
|
740,696 |
|
|
|
1,674,618 |
|
|
|
1,866,756 |
|
Litigation expenses |
|
|
17,145 |
|
|
|
1,998 |
|
|
|
21,545 |
|
|
|
10,208 |
|
Engineering, research, and development |
|
|
574,118 |
|
|
|
492,432 |
|
|
|
1,950,545 |
|
|
|
1,678,940 |
|
Total operating expenses |
|
|
1,115,229 |
|
|
|
1,235,126 |
|
|
|
3,646,708 |
|
|
|
3,555,904 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations |
|
|
292,564 |
|
|
|
(224,037 |
) |
|
|
1,443,738 |
|
|
|
326,619 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (expense) income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
996 |
|
|
|
1,591 |
|
|
|
2,977 |
|
|
|
6,316 |
|
Other income |
|
|
- |
|
|
|
758 |
|
|
|
35,854 |
|
|
|
14,612 |
|
Gain on forgiveness of PPP loan |
|
|
- |
|
|
|
722,577 |
|
|
|
722,577 |
|
|
|
722,577 |
|
Interest expense – judgement |
|
|
(52,490 |
) |
|
|
(52,490 |
) |
|
|
(156,901 |
) |
|
|
(180,124 |
) |
Interest expense |
|
|
- |
|
|
|
(8,030 |
) |
|
|
- |
|
|
|
(27,190 |
) |
Total other net (expense) income |
|
|
(51,494 |
) |
|
|
664,406 |
|
|
|
604,507 |
|
|
|
536,191 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes |
|
|
241,070 |
|
|
|
440,369 |
|
|
|
2,048,245 |
|
|
|
862,810 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax (benefit) expense |
|
|
46,448 |
|
|
|
(59,264 |
) |
|
|
278,446 |
|
|
|
29,449 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
194,622 |
|
|
|
499,633 |
|
|
|
1,769,799 |
|
|
|
833,361 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred dividends |
|
|
(80,000 |
) |
|
|
(80,000 |
) |
|
|
(240,000 |
) |
|
|
(240,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to common shareholders |
|
$ |
114,622 |
|
|
$ |
419,633 |
|
|
$ |
1,529,799 |
|
|
$ |
593,361 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income per common share |
|
$ |
0.04 |
|
|
$ |
0.13 |
|
|
$ |
0.47 |
|
|
$ |
0.18 |
|
Diluted income per common share |
|
$ |
0.04 |
|
|
$ |
0.10 |
|
|
$ |
0.35 |
|
|
$ |
0.16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
3,255,887 |
|
|
|
3,255,887 |
|
|
|
3,255,887 |
|
|
|
3,255,887 |
|
Diluted |
|
|
5,095,665 |
|
|
|
5,095,665 |
|
|
|
5,095,665 |
|
|
|
5,065,665 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220211005048/en/
(201) 933-1600
Source:
FAQ
What were Tel-Instrument Electronics Corp's Q3 2022 revenues?
What is the stock symbol for Tel-Instrument Electronics Corp?
How much was the net income for Tel-Instrument in Q3 FY2022?
What challenges is Tel-Instrument facing in Q4 2022?